INTRODUCTION
============

Nuclear factor-κB (NF-κB) plays an important role in immune and inflammatory responses by regulating genes encoding pro-inflammatory cytokines, adhesion molecules, chemokines, growth factors, and inducible enzymes ([@b16-55-61_bt22-1]; [@b8-55-61_bt22-1]). Therefore, NF-κB pathway inhibitors act as anti-inflammatory compounds ([@b20-55-61_bt22-1]; [@b18-55-61_bt22-1]). Although inflammation is a basic response to injury or infection, the harmful effects of inflammation can cause a variety of chronic diseases including arthritis, fibrosis, and cancer. Inflammatory responses also play important roles in the development of liver disease in both humans and animals. Hepatitis, which can be either acute or chronic, results from inflammation of the liver, and is characterized by the presence of hepatic inflammatory cells. Chronic hepatitis is associated with a high risk of hepatic carcinoma ([@b2-55-61_bt22-1]). At the molecular level, free radicals and aldehydes produced during chronic hepatitis can induce deleterious gene mutations and posttranslational modifications in cancer-associated genes ([@b11-55-61_bt22-1]). Other inflammatory products, including cytokines, growth factors, and transcription factors such as nuclear factor-κB (NF-κB), regulate the expression of cancer-related (both tumor suppressor genes and oncogenes) and key inflammatory genes, such as interleukin-8 (IL-8), chemokine (C-X-C motif) ligand-1 (CXCL-1), inducible nitric oxide synthase (iNOS), and intercellular adhesion molecule-1 (ICAM-1) ([@b15-55-61_bt22-1]; [@b4-55-61_bt22-1]; [@b10-55-61_bt22-1]; [@b6-55-61_bt22-1]).

*Panax ginseng* (PG) Meyer (Araliaceae), a traditional herbal drug in Oriental medicine, is used to treat a variety of diseases ([@b9-55-61_bt22-1]; [@b5-55-61_bt22-1]; [@b31-55-61_bt22-1]). Ginsenosides are the major active components of PG. Although roots are considered to be the best source of PG, leaves also contain high concentrations of ginsenosides ([@b25-55-61_bt22-1]; [@b17-55-61_bt22-1]; [@b26-55-61_bt22-1]). Therefore, ginseng leaves could function as a supplementary source of pharmacologically active ginsenosides ([@b3-55-61_bt22-1]; [@b32-55-61_bt22-1]).

Traditionally, PG root is air-dried, yielding white ginseng, or steamed at 100°C to produce red ginseng. Steamed ginseng is believed to be more pharmacologically effective than air-dried ginseng. The differences in the biological effects of air-dried and steamed ginseng are attributed to significant changes to ginsenosides during steaming ([@b1-55-61_bt22-1]). However, the anti-inflammatory effects of steamed PG from flowers have not been assessed.

Our previous studies focused on identifying the bioactive constituents in steamed FBPG, leading to the identification of one dammarane-type saponin, ginsenoside SF, and 17 known saponins, including ginsenoside Rh~4~, ginsenoside Rk~3~, ginsenoside F~1~, (20*E*)-ginsenoside F~4~, ginsenoside Rg~2~, pseudoginsenoside RC~1~, ginsenoside Rg~6~, ginsenoside Rs~4~, ginsenoside Rg~1~, 6'-acetyl-ginsenoside Rg~1~, ginsenoside Rb~1~, ginsenoside Rc, ginsenoside Rb~2~, ginsenoside Re, vinaginsenoside R~4~, ginsenoside Mb, and ginsenoside F~4~ ([@b27-55-61_bt22-1]). Some of these compounds possess antioxidant and anticancer activities, and inhibit LPS-stimulated IL-12 production ([@b28-55-61_bt22-1], [@b29-55-61_bt22-1], [@b30-55-61_bt22-1]).

In this study, the effects of 18 ginsenosides, isolated from steamed FBPG, on TNF-α-induced NF-κB transcriptional activity in human hepatocyte-derived cells (HepG2 and SKHep1) were evaluated using an NF-κB-luciferase assay. Their effects on iNOS promoter activity, and the expression of NF-κB target genes, including interleukin-8 (IL-8), chemokine (CX-C motif) ligand-1 (CX-CL-1), inducible nitric oxide synthase (iNOS), and intercellular adhesion molecule-1 (ICAM-1), were evaluated by RT-PCR in TNF-α-stimulated cells.

MATERIALS AND METHODS
=====================

Chemical and sample preparation
-------------------------------

Ginsenosides were isolated from the steamed flower buds of *Panax ginseng* (FBPG) as identified in our previous reports ([@b27-55-61_bt22-1]). Apigenin, potently inhibited the transcriptional activity of NF-κB ([@b7-55-61_bt22-1]), was the product of Sigma-Aldrich. All other chemicals and reagents were of analytical grade. The tested ginsenosides and apigenin (Sigma-Aldrich) were dissolved in DMSO.

Cell lines and culture
----------------------

HepG2 and SK-Hep1 cells were maintained in Dulbecco's modified Eagle's medium (Invitrogen, Carlsbad, CA, USA) containing 10% heat-inactivated fetal bovine serum, 100 units/ml penicillin, and 10 μg/ml streptomycin, at 37°C and 5% CO~2~. Human TNF-α was purchased from ATgen (Seoul, Korea).

Cell toxicity assay
-------------------

Cell-Counting Kit (*CCK*)-8 (*Dojindo*, Kumamoto, Japan) was used to analyze the effect of compounds on cell toxicity according to the manufacturer's instructions. Cells were cultured overnight in 96-well plate (∼1×10^4^ cells/well). Cell toxicity was assessed after the addition of compounds on dose-dependent manner. After 24 h of treatment, 10 μl of the CCK-8 solution was added to triplicate wells, and incubated for 1 h. Absorbance was measured at 450 nm to determine viable cell numbers in wells.

NF-κB and iNOS-luciferase assay
-------------------------------

Human hepatocarcinoma HepG2 and SK-Hep1 cells were maintained in Dulbecco's modified Eagles' medium (DMEM) (Invitrogen, Carlsbad, CA, USA) containing 10% heat-inactivated fetal bovine serum (FBS), 100 units/ml penicillin, and 10 μg/ml streptomycin at 37°C and 5% CO~2~. The luciferase vector was first transfected into cells. After a limited amount of time, the cells were lysed, and luciferin, the substrate of luciferase, was introduced into the cellular extract along with Mg^2+^ and an excess of ATP. Under these conditions, luciferase enzymes expressed by the reporter vector could catalyze the oxidative carboxylation of luciferin. Cells were seeded at 2×10^5^ cells per well in a 12-well plate and grown. After 24 h, cells were transfected with inducible NF-κB or iNOS firefly luciferase reporter and constitutively expressing Renilla reporter. After 24 h of transfection, medium was changed to assay medium (Opti-MEM+0.5% FBS+0.1 mM NEAA+1 mM sodium pyruvate+100 units/ml penicillin+10 μg/ml streptomycin) and cells were pretreated for 1 h with either vehicle (DMSO) and compounds, followed by 1 h of treatment with 10 ng/ml TNF-α for 20 h. Unstimulated cells were used as a negative control (--), apigenin was used as a positive control. Dual Luciferase assay was performed 48 h after transfection, and promoter activity values are expressed as arbitrary units using a Renilla reporter for internal normalization.

RNA preparation and reverse transcriptase polymerase chain reaction (RT-PCR)
----------------------------------------------------------------------------

RNA Preparation and Reverse Transcriptase Polymerase Chain Reaction (RT-PCR): Total RNA was extracted using Easy-blue reagent (Intron Biotechnology, Seoul, Korea). Approximately 2 μg total RNA was subjected to reverse transcription using Moloney murine leukemia virus (MMLV) reverse transcriptase and oligo-dT primers (Promega, Madi-son, WI, USA) for 1 h at 42°C. PCR for synthetic cDNA was performed using a Taq polymerase pre-mixture (TaKaRa, Japan). The PCR products were separated by electrophoresis on 1% agarose gels and stained with EtBr. PCR was conducted with the following primer pairs: *iNOS* sense 5′-TCATCCGCTATGCTGGCTAC-3′, *iNOS* antisense 5′-CTCAGGGTCACGGCCATTG-3′, *ICAM-1* sense 5′-CTGCAGACAGTGACCATC-3′, *ICAM-1* antisense 5′-GTCCAGTTTCCCGGACAA-3′, *IL-8* sense 5′-GGGTCTGTTGTAG-GGTTGCC-3′, *IL-8* antisense 5′-TCTGGATCCTGGCTAGCA-GA-3′, *CXCL-1* sense 5′-AGGGAATTCACCCCAAGAAC-3′, *CXCL-1* antisense 5′-5′-TAACTATGGGGGATGCAGGA-3′, β-actin sense 5′-TCACCCACACTGTGCCCATCTACG-3′, and β-actin antisense 5′-CAGCGGAACCGCTCATTGCCAATG-3′. HepG2 and SK-Hep1 cells were pretreated in the absence and presence of compounds for 1 hr, then exposed to 10 ng/ml TNF-α for 6 h. Total mRNA was prepared from the cell pellets using Easy-blue. The levels of mRNA were assessed by RT-PCR.

Statistical analysis
--------------------

Unless otherwise stated, all experiments were performed with triplicate samples and repeated at least three times. All results are expressed as the mean ± S.E.M. Data was analyzed by one-factor analysis of variance (ANOVA). Upon observation of a statistically significant effect, the Newman-Keuls test was performed to determine the difference between the groups. A *p* value ^\*^(\<0.05) and ^\*\*^(\<0.01) were considered to be significant.

RESULTS
=======

Ginsenosides inhibit NF-κB activity in hepatocyte-derived cell lines
--------------------------------------------------------------------

To identify novel NF-κB inhibitors from the steamed flower buds of *Panax ginseng* (FBPG), 18 dammarane-type ginsenosides were evaluated using the NF-κB reporter system. To determine non-toxic concentrations, HepG2 cells were treated with 0.1, 1, and 10 μM of each compound, and cell viability was assessed by MTS assay. No compounds were significantly cytotoxic at up to 10 μM, suggesting that NF-κB inhibition was not toxic (data not shown). HepG2 cells were then pre-treated with different ginsenosides at concentrations ranging from 0.01 to 10 μM for 1 h, and induced with TNF-α for 20 h. Rk~3~ and Rs~4~ significantly inhibited TNF-α-induced NF-κB transcriptional activity, with IC~50~ values of 14.24 ± 1.30 and 12.44 ± 2.01 μM, respectively ([Table 1](#t1-55-61_bt22-1){ref-type="table"}, [Fig. 1](#f1-55-61_bt22-1){ref-type="fig"}, [2](#f2-55-61_bt22-1){ref-type="fig"}). SF and Rg~6~ also reduced NF-κB transcriptional activity, with IC~50~ values of 33.86 ± 4.14 and 29.34 ± 2.22 μM, respectively ([Table 1](#t1-55-61_bt22-1){ref-type="table"}, [Fig. 1](#f1-55-61_bt22-1){ref-type="fig"}, [2](#f2-55-61_bt22-1){ref-type="fig"}). Six additional ginsenosides F~1~, Rg~1~, Rb~1~, and Rb~2~, (20*E*)-ginsenoside F~4~, and pseudoginsenoside RC~1~ moderately inhibited the transcriptional activity of NF-κB with IC~50~ values of 42.51 ± 1.97, 45.47 ± 3.64, 61.22 ± 3.69, 37.46 ± 5.01, 89.62 ± 10.64, and 98.24 ± 7.61 μM, respectively ([Fig. 2](#f2-55-61_bt22-1){ref-type="fig"}). Finally, ginsenosides Rh~4~, Rg~2~, Rc, Re, Mb, F~4~, 6'-acetyl-ginsenoside Rg~1~, and vinaginsenoside R~4~ had no effect ([Fig. 2](#f2-55-61_bt22-1){ref-type="fig"}). Apigenin, the positive control, potently inhibited the transcriptional activity of NF-κB, with an IC~50~ of 1.64 ± 0.19 μM. These results suggest that the ginsenosides SF, Rk~3~, Rg~6~, and Rs~4~ inhibited TNF-α-induced NF-κB transcriptional activity in HepG2 cells.

To confirm that these compounds inhibited NF-κB activation in HepG2 cells, their effects on TNF-α-induced NF-κB transcriptional activity in SK-Hep1 cells were evaluated using the NF-κB reporter system. Cells were pretreated with the four ginsenosides at concentrations ranging from 0.01 to 10 μM for 1 h, and then induced with TNF-α for 20 h. SF, Rk3, Rg~6~, and Rs~4~ significantly inhibited TNF-α-induced NF-κB transcriptional activity, with IC~50~ values of 10.17 ± 0.69, 15.32 ± 0.29, 25.12 ± 1.04, and 11.98 ± 0.85 μM, respectively, consistent with the data from HepG2 cells ([Table 1](#t1-55-61_bt22-1){ref-type="table"}, [Fig. 3](#f3-55-61_bt22-1){ref-type="fig"}). As expected, apigenin potently inhibited NF-κB transcriptional activity, with an IC~50~ of 3.60 ± 0.21 μM. These data suggest that the ginsenosides SF, Rk~3~, Rg~6~, and Rs~4~ inhibited TNF-α-induced NF-κB transcriptional activity in HepG2 and SK-Hep1 cells.

Effect of ginsenosides on NF-κB target genes expression
-------------------------------------------------------

NF-κB regulates several genes involved in immunity, inflammation, and cell proliferation, as well as those that result in the negative feedback of NF-κB signaling ([@b8-55-61_bt22-1]). Therefore, we assessed expression of NF-κB target genes that play an important role in the inflammatory response, including IL-8 (cytokine), CXCL-1 (chemokine), ICAM-1 (migration), and iNOS (inflammatory inducible enzyme), in HepG2 and SK-Hep1 cells treated with ginsenosides ([Fig. 4](#f4-55-61_bt22-1){ref-type="fig"}). Consistent with the inhibition of NF-κB, SF, Rk~3~, Rg~6~, and Rs~4~ all inhibited the induction of *IL8*, *CXCL1*, *iNOS*, and *ICAM1* mRNA significantly in a dose-dependent manner, suggesting that these compounds reduced the transcription of these genes. Importantly, the expression of the housekeeping protein β-actin was unchanged by ginsenosides.

The ginsenosides SF, Rk~3~, Rg~6~, and Rs~4~ also decreased TNF-α-induced iNOS promoter activity, with IC~50~ values ranging from 6 to 20 μM ([Table 1](#t1-55-61_bt22-1){ref-type="table"}, [Fig. 5](#f5-55-61_bt22-1){ref-type="fig"}). These data suggest that the dammarane-type ginsenosides isolated from steamed FBPG suppress TNF-α-induced NF-κB transcriptional activity via the inhibition of iNOS gene transcription.

DISCUSSION
==========

The aim of the present study was to identify novel inhibitors of NF-κB, a transcription factor that is a major target in drug discovery due to its causative role in inflammation, cancer, and many other diseases. Eighteen ginsenosides were isolated from the flower buds of *Panax ginseng* (FBPG), and their ability to inhibit TNF-α-induced NF-κB activation was assessed. Four ginsenosides (22%) inhibited NF-κB activity at a concentration of 10 μM. This high percentage of active compounds was not a surprise, since extracts from ginseng and saponins are recognized as promising NF-κB inhibitors. For example, the NF-κB-inhibiting saponin ginsenosides Rd, Re, and Rp~1~ are currently being assessed in preclinical and clinical trials ([@b21-55-61_bt22-1]; [@b13-55-61_bt22-1]; [@b33-55-61_bt22-1]).

In this study, the ginsenosides SF, Rk~3~, Rg~6~, and Rs~4~ inhibited TNF-α-induced NF-κB promoter activity in hepatocyte-derived HepG2 and SK-Hep1 cells in a dose-dependent manner by modulating gene transcription. They also inhibited the transcription of the NF-κB target genes *IL8*, *CXCL1*, *iNOS*, and *ICAM1*, as demonstrated by reduced mRNA expression in TNF-α-treated HepG2 and SK-Hep1 cells. To our knowledge, this is the first report of these effects. Of the remaining compounds, ginsenosides F~1~, Rg~1~, Rb~1~, Rb~2~, (20*E*)-ginsenoside F~4~, and pseudoginsenoside RC~1~ exerted only small inhibitory effects, with IC~50~ values of 42.51, 45.47, 61.22, 37.46, 89.62, and 98.24 μM, respectively. Furthermore, ginsenosides Rh~4~, Rg~2~, Rc, Re, Mb, F~4~, 6'-acetyl-ginsenoside Rg~1~, and vinaginsenoside R~4~ had no effect.

We demonstrated previously that ginsenosides F~1~, Rg~1~, Rb~1~, and Rb~2~, isolated from the air dried leaves of *Panax ginseng*, moderately inhibited NF-κB in HepG2 cells ([@b22-55-61_bt22-1]). Furthermore, ginsenoside Rc and Re had no effects, consistent with this study.

We also reported that the ginsenoside Rg~6~ potently inhibited LPS-induced IL-12 production by 82% in bone marrow-derived dendritic cells ([@b30-55-61_bt22-1]). Consistent with this, ginsenoside Rg~6~ also exerted anti-complement effects, with an IC~50~ of 174 μM, in antibody-sensitized sheep erythrocytes (EA) as indicator cells ([@b14-55-61_bt22-1]). Ginsenoside Rk~3~ exerts cardioprotective effects against hypoxia-reoxygenation injury via the phosphatidylinositol 3-kinase (PI3K)/AKT and mitogen-activated protein kinase (MAPK) signaling pathways in H9c2 cardiomyocytes ([@b23-55-61_bt22-1]). In addition, ginsenoside Rk~3~ and Rs~4~ exert anti-proliferative effects, with IC~50~ values of 187 and 20 μM, respectively, in human hepatocarcinoma cells ([@b12-55-61_bt22-1]; [@b24-55-61_bt22-1]). Inhibiting NF-κB by blocking TNF-α resulted in apoptosis in transformed hepatocytes, and inhibited hepatocarcinogenesis. Therefore, the NF-κB signaling pathway may have pro-carcinogenic effects, and so may be a potential target for novel anti-tumor agents ([@b19-55-61_bt22-1]). Based on our data, we suggest that the ginsenosides SF, Rk~3~, Rg~6~, and Rs~4~ may act as NF-κB pathway inhibitors that could be applied as targeted therapies for conditions such as inflammatory hepatic cancer and inflammatory hepatitis.

In conclusion, we demonstrated that the ginsenosides SF, Rk~3~, Rg~6~, and Rs~4~, isolated from steamed flower buds of *Panax ginseng*, suppressed TNF-α-induced NF-κB activation, which subsequently inhibited the expression of *IL8*, *CXCL1*, *iNOS*, and *ICAM1* in hepatocyte-derived HepG2 and SK-Hep1 cells. Our data demonstrated that these compounds have therapeutic potential as anti-inflammatory agents. However, the detailed mechanism by which they inhibit TNF-α-induced NF-kB activation remains to be elucidated.
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![Chemical structures of the ginsenosides SF, Rk~3~, Rg~6~, and Rs~4~.](BT-22-55-g001){#f1-55-61_bt22-1}

![Effect of 18 ginsenosides on TNF-α-stimulated NF-κB transcriptional activity in HepG2 cells. Cells transiently transfected with pNF-κB-Luc were pretreated for 1 h with either vehicle (DMSO) or compounds, then treated with TNF-α (10 ng/ml). Unstimulated cells acted as a negative control. Cells were harvested and assayed for luciferase activity. Apigenin was used as a positive control (+). Results are expressed as the mean luciferase activity ± S.E.M. (n=3). Statistical significance is indicated as ^\*^*p*\<0.05, ^\*\*^*p*\<0.01.](BT-22-55-g002){#f2-55-61_bt22-1}

![Effect of ginsenosides SF, Rk~3~, Rg~6~, and Rs~4~ on TNF-α stimulated NF-κB transcriptional activity in SK-Hep1 cells. Cells transiently transfected with pNF-κB-Luc were pretreated for 1 h with either vehicle (DMSO) or compounds, then treated with TNF-α (10 ng/ml). Unstimulated cells acted as a negative control. Cells were harvested and assayed for luciferase activity. Results are expressed as the mean luciferase activity ± SEM (n=3). Statistical significance is indicated as ^\*^*p*\<0.05, ^\*\*^*p*\<0.01.](BT-22-55-g003){#f3-55-61_bt22-1}

![Effect of ginsenosides SF, Rk~3~, Rg~6~, and Rs~4~ on *IL-8*, *CXCL-1*, *iNOS*, and *ICAM-1* gene expression in HepG2 and SK-Hep1 hepatocyte-derived cells. HepG2 and SK-Hep1 cells were pretreated with the ginsenosides SF, Rk~3~, Rg~6~, and Rs~4~, or the vehicle (DMSO), for 1 hour, then treated with TNF-α (10 ng/ml) for 6 h. Total mRNA was extracted from the cell pellets using TRIzol reagent. Relative mRNA levels were assessed by RT-PCR. Expression levels are displayed as the ratio of *IL-8*, *CXCL-1*, *iNOS*, and *ICAM-1* signal strength to a reference gene (β-actin), compensating for variations in the RNA concentrations.](BT-22-55-g004){#f4-55-61_bt22-1}

![Effect of ginsenosides SF, Rk~3~, Rg~6~, and Rs~4~ on TNF-α-stimulated iNOS promoter activity. HepG2 and SK-Hep1 cells transiently transfected with iNOS-Luc were pretreated for 1 h with either vehicle (DMSO) or compounds, then treated with TNF-α (10 ng/ml). Unstimulated HepG2 and SK-Hep1 cells acted as a negative control. Cells were harvested and assayed for luciferase activity. Results are expressed as the mean luciferase activity ± S.E.M. (n=3). Statistical significance is indicated as ^\*^*p*\<0.05, ^\*\*^*p*\<0.01.](BT-22-55-g005){#f5-55-61_bt22-1}

###### 

Inhibitory effects of ginsenosides SF, Rk~3~, Rg~6~, and Rs~4~ on the TNF-α-induced NF-κB transcriptional activity and iNOS promoter activity in HepG2 and SK-Hep1 hepatocyte-derived cells

  Ginsenoside or Compound                                     IC~50~ (μM)[^\*^](#tfn1-55-61_bt22-1){ref-type="table-fn"}                                 
  ----------------------------------------------------------- ------------------------------------------------------------ -------------- -------------- --------------
  Ginsenoside SF                                              33.86 ± 4.14                                                 13.07 ± 0.64   18.17 ± 0.69   11.26 ± 0.87
  Ginsenoside Rk~3~                                           14.24 ± 1.30                                                 9.83 ± 0.06    15.32 ± 0.29   6.02 ± 0.37
  Ginsenoside Rg~6~                                           29.34 ± 2.22                                                 19.45 ± 0.55   25.12 ± 1.04   10.36 ± 0.69
  Ginsenoside Rs~4~                                           12.44 ± 2.01                                                 10.01 ± 1.21   11.98 ± 0.85   6.92 ± 0.65
  Apigenin[^\*\*^](#tfn2-55-61_bt22-1){ref-type="table-fn"}   1.64 ± 0.19                                                  4.45 ± 0.24    3.60 ± 0.21    3.63 ± 0.17

Results are the means ± SEM of three independent experiments performed in triplicate.
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